TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Clinical trial NCT04246671 · COMPLETED

Trial details

NCT number: NCT04246671
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chordoma HER2-positive Breast Cancer

Start date: 2020-08-10
Primary completion: 2024-02-17
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.